| 53BP1 | TP53-binding protein 1 |
| 5-FU | 5-fluorouracil |
| AKT | RAC-alpha serine/threonine-protein kinase |
| APC | Antigen-presenting cell |
| APAF-1 | Apoptotic protease-activating factor 1 |
| ATM | Serine-protein kinases ataxia telangiectasia mutated |
| ATRIP | ATR-interacting protein |
| BAD | Bcl2-associated agonist of cell death |
| BAP31 | B-cell receptor-associated protein 31 |
| BER | Base excision repair |
| BRAF | Serine/threonine-protein kinase B-raf |
| BRCA1/2 | Breast cancer type 1 susceptibility protein 1/2 |
| CDC25A/C | M-phase inducer phosphatases |
| CDK | Cyclin-dependent kinase |
| cGAS | Cyclic GMP-AMP synthase |
| CHK1/2 | Serine/threonine-protein kinase CHK1/2 |
| CK2 | Casein kinase II |
| COX2 | Cyclooxygenase-2 |
| CRT | Calreticulin |
| CSC | Cancer stem cells |
| CtIP | CtBP-interacting protein |
| DAMPS | Damage-associated molecular pattern molecules |
| DCs | Dendritic cells |
| DDR | DNA damage response |
| DISC | Death-inducing signaling complex |
| DNA-PKcs | DNA-dependent protein kinase catalytic subunit |
| DSBR | Double-strand break repair |
| DSBs | Double-strand breaks |
| ED | Extracellular domain |
| eIF2α | Eukaryotic translation initiation factor 2A |
| EMT | Epithelial-to-mesenchymal transition |
| ERK | Extracellular signal-regulated kinase |
| ES-SCLC | Extensive-stage small cell lung cancer |
| EXO1 | Exonuclease 1 |
| FA | Fanconi anemia |
| FADD | FAS-associated death domain protein |
| FdUMP | 5-fluoro-2′-deoxyuridine 5′-monophosphate |
| FdUTP | Fluorodeoxyuridine triphosphate |
| FLIP | Flice-like inhibitory protein |
| FOXO1 | Forkhead box protein O1 |
| GADD45 | 45kd-growth arrest and DNA damage |
| GDSM | Gasdermin |
| GZMA/B | Granzyme A/B |
| HIF-1α | Hypoxia-inducible factor alpha |
| HMG1/2 | Nonhistone chromosomal high-mobility group 1 and 2 |
| HMGB1 | High mobility group protein 1 |
| HR | Homologous recombination |
| hUBF | Highly similar to Human upstream binding factor |
| ICD | Immunogenic cell death |
| ICLs | Interstrand crosslinks |
| ICT | Intracellular cytoplasmic tail |
| IFN | Interferon |
| IL | Interleukin |
| ILC2s | Group 2 innate lymphoid cells |
| irAEs | Immune-related adverse effects |
| IRF | Interferon regulatory factor |
| ITIM | Immunoreceptor tyrosine-based inhibitory motif |
| ITSM | Immunoreceptor tyrosine-based switch motif |
| JAK | Tyrosine-protein kinase |
| JNK | Jun amino-terminal kinase |
| KU70/80 | X-ray repair cross-complementing protein 5/6 |
| M2 | Tumor-associated macrophages M2 |
| mAbs | Monoclonal antibodies |
| MCM2/7 | Minichromosome maintenance complex |
| MDC-1 | Mediator of DNA damage checkpoint protein 1 |
| MDM2 | Mouse double minute 2 homolog |
| MDSC | Myeloid-derived suppressor cells |
| MDSCs | Myeloid-derived suppressor cells |
| MEK | Dual specificity mitogen-activated protein kinase kinase |
| MHC | Major histocompatibility complex |
| MLH1 | DNA mismatch repair protein MLH1 |
| MMR | Mismatch repair |
| mPGES1 | Prostaglandin E synthase |
| MRE11 | Double-strand break repair protein MRE11 |
| MSH2/6 | DNA mismatch repair protein MSH2/6 |
| MSI | Microsatellite instability |
| mtDNA | Mitochondrial DNA |
| mTOR | Serine/threonine-protein kinase mTOR |
| Nal-IRI | Liposomal irinotecan |
| NBS1 | Nibrin |
| nDNA | Nuclear DNA |
| NER | Nucleotide excision repair |
| NF-Kβ | Nuclear factor NF-kappa-B p105 subunit |
| NHEJ | Non-homologous end joining |
| NK | Natural killer cells |
| OMI | Serine protease HTRA2 |
| OS | Overall survival |
| P2RX7 | P2X purinoceptor 7 |
| PAR | Polymer ADP-ribose residues |
| PARP-1 | Poly [ADP-ribose] polymerase 1 |
| PARPi | PARP inhibitor |
| PD-1/PD-L1 | Programmed death receptor-1/programmed death ligand-1 |
| PERK | Eukaryotic translation initiation factor 2-alpha kinase 3 |
| PFN | Perforins |
| PFS | Progression-free survival |
| PGE2 | Prostaglandin E2 |
| PI3K | Phosphatidylinositol-4,5-bisphosphate 3-kinase |
| PKC | Protein kinase C |
| PLCg-1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 |
| PLK | Serine/threonine-protein kinase PLK |
| PRR | Pattern recognition receptors |
| PS | Phosphatidylserine |
| PTEN | Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase |
| RAD50 | DNA repair protein RAD50 |
| RAD51 | DNA repair protein RAD51 homolog 1 |
| RAD52 | DNA repair protein RAD52 homolog |
| RAP80 | Receptor-associated protein 80 |
| RNF4, -8, -168 | E3 ubiquitin-protein ligases |
| ROS | Reactive oxygen species |
| RPA | Replication protein A |
| SCLC | Small-cell lung cancer |
| SHP1/2 | Src homology region 2 domain containing phosphatases |
| SMACK | Diablo IAP-binding mitochondrial protein |
| SSBR | Single-strand break repair |
| ssDNA | Single-stranded DNA |
| STAT | Signal transducer and activator of transcription |
| STING | Stimulator of interferon genes protein |
| TBP | TATA binding protein |
| TCR | T-cell receptor |
| TGF-β | Transforming growth factor β |
| TICs | Tumor-initiating cells |
| TILs | Tumor infiltrating lymphocytes |
| TLR | Toll-like receptor |
| TLS | Translesion DNA synthesis |
| TM | Transmembrane domain |
| TMB | Tumor mutational burden |
| TNF-α | Tumor necrosis factor α |
| TOPBP1 | Topoisomerase 2-binding protein 1 |
| TP53 | Cellular tumor antigen p53 |
| Tregs | Regulatory T cells |
| WAF1/CIP1 | Cyclin-dependent kinase inhibitor 1 |
| XLF | Non-homologous end-joining factor 1 |
| XRCC4 | X-ray repair cross-complementing protein 4 |